Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $122.51 | 2 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ARGENX US, INC. | $98.70 | 1 | $0 (2023) |
| Abbott Laboratories | $23.81 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $23.81 | 1 | Abbott Laboratories ($23.81) |
| 2023 | $98.70 | 1 | ARGENX US, INC. ($98.70) |
All Payment Transactions
2 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/16/2024 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: Cardiac Rhythm Management | ||||||
| 08/29/2023 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $98.70 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 1,161 | 1,470 | $136,865 | $44,083 |
| 2022 | 13 | 358 | 407 | $39,332 | $15,559 |
| 2021 | 16 | 816 | 945 | $108,140 | $37,323 |
| 2020 | 13 | 476 | 584 | $44,600 | $20,262 |
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 122 | 170 | $37,570 | $11,676 | 31.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 126 | 182 | $29,120 | $9,745 | 33.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 49 | 49 | $4,116 | $3,525 | 85.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 19 | $5,966 | $2,049 | 34.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 61 | 65 | $3,575 | $1,938 | 54.2% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 14 | 14 | $3,598 | $1,831 | 50.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 127 | 172 | $5,504 | $1,780 | 32.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 99 | 156 | $10,920 | $1,485 | 13.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 126 | 173 | $4,844 | $1,317 | 27.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 86 | 90 | $6,300 | $1,181 | 18.7% |
| 84681 | C-peptide (protein) level | Office | 2023 | 42 | 43 | $4,816 | $876.77 | 18.2% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 22 | 29 | $2,291 | $817.76 | 35.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 13 | 13 | $793.00 | $777.14 | 98.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 39 | 46 | $2,622 | $757.16 | 28.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 13 | 14 | $1,834 | $659.91 | 36.0% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 11 | 12 | $900.00 | $603.36 | 67.0% |
| 0134A | Adm sarscv2 bvl 50mcg/.5ml a | Office | 2023 | 13 | 13 | $520.00 | $509.60 | 98.0% |
| 82306 | Vitamin d-3 level | Office | 2023 | 15 | 17 | $2,550 | $493.17 | 19.3% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 11 | 11 | $440.00 | $431.20 | 98.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 14 | 14 | $826.00 | $417.34 | 50.5% |
| 82274 | Stool analysis for blood, by fecal hemoglobin determination by immunoassay | Office | 2023 | 20 | 20 | $1,400 | $312.00 | 22.3% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 60 | 73 | $1,022 | $234.33 | 22.9% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 13 | 13 | $2,067 | $232.44 | 11.2% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 21 | 25 | $2,450 | $221.00 | 9.0% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 15 | 19 | $551.00 | $157.51 | 28.6% |
About Dr. Lorie Jones, MD
Dr. Lorie Jones, MD is a Internal Medicine healthcare provider based in Kayenta, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/02/2005. The National Provider Identifier (NPI) number assigned to this provider is 1427049014.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lorie Jones, MD has received a total of $122.51 in payments from pharmaceutical and medical device companies, with $23.81 received in 2024. These payments were reported across 2 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($122.51).
As a Medicare-enrolled provider, Jones has provided services to 2,811 Medicare beneficiaries, totaling 3,406 services with total Medicare billing of $117,227. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Kayenta, AZ
- Active Since 11/02/2005
- Last Updated 01/08/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1427049014
Products in Payments
- VYVGART (Drug) $98.70
- JOT DX (Device) $23.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.